Investigator-Initiated, Pilot Translational Study of Circulating Tumor Cells to Identify Predictive Factors of Response to Abiraterone Acetate in Men With Castration-Resistant Prostate Cancer
Latest Information Update: 27 May 2024
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Biomarker; Therapeutic Use
- 21 May 2024 Planned End Date changed from 1 Dec 2021 to 31 Dec 2024.
- 21 May 2024 Planned primary completion date changed from 1 Dec 2021 to 30 Jun 2024.
- 10 Apr 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.